|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 323.87 USD | +0.99% |
|
+4.59% | +6.60% |
| 16/04 | Terremoto Biosciences, Inc. announced that it has received $108 million in funding from a group of investors | CI |
| 15/04 | Molecular Partners AG Announces Board and Committee Appointments | CI |
| Capitalization | 35.92B 30.43B 27.99B 26.49B 49.1B 3,323B 49.96B 328B 129B 1,611B 135B 132B 5,678B | P/E ratio 2026 * |
58.5x | P/E ratio 2027 * | 35.1x |
|---|---|---|---|---|---|
| Enterprise value | 32.47B 27.51B 25.31B 23.95B 44.39B 3,005B 45.17B 296B 116B 1,457B 122B 119B 5,134B | EV / Sales 2026 * |
5.08x | EV / Sales 2027 * | 4.32x |
| Free-Float |
96.17% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: BeOne Medicines AG
| 1 day | +0.99% | ||
| 1 week | +4.59% | ||
| Current month | +9.06% | ||
| 1 month | +12.72% | ||
| 3 months | -4.23% | ||
| 6 months | +2.35% | ||
| Current year | +6.60% |
| 1 week | 302.53 |  | 328.39 |
| 1 month | 271.47 | | 328.39 |
| Current year | 271.47 | | 372.73 |
| 1 year | 218.31 | | 385.22 |
| 3 years | 126.97 | | 385.22 |
| 5 years | 118.18 | | 426.56 |
| 10 years | 24.53 | | 426.56 |
| Manager | Title | Age | Since |
|---|---|---|---|
John Oyler
CEO | Chief Executive Officer | 57 | 28/10/2010 |
Xiao Bin Wu
PSD | President | 64 | 01/04/2018 |
Aaron Rosenberg
DFI | Director of Finance/CFO | 50 | 22/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Oyler
CHM | Chairman | 57 | 27/01/2016 |
Michael Goller
BRD | Director/Board Member | 51 | 01/04/2015 |
Ranjeev Krishana
BRD | Director/Board Member | 52 | 01/10/2014 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.99% | +4.59% | +40.22% | +22.31% | 35.57B | |
| +2.22% | +5.51% | +0.78% | -7.93% | 47.35B | |
| -0.43% | +54.13% | +304.33% | +504.92% | 31.16B | |
| -0.72% | +3.91% | +35.55% | +29.11% | 29.62B | |
| +2.62% | +5.45% | +22.62% | -12.91% | 28.86B | |
| -6.22% | -0.52% | +3,641.35% | +3,836.02% | 15.12B | |
| +0.63% | +2.17% | +48.12% | +195.41% | 15.01B | |
| +0.96% | +5.48% | +75.71% | +166.26% | 14.73B | |
| +0.87% | +8.85% | +40.89% | +13.56% | 14.34B | |
| +0.60% | +0.72% | +166.58% | +100.40% | 12.43B | |
| Average | +0.15% | +8.90% | +437.62% | +484.72% | 24.42B | |
| Weighted average by Cap. | +0.54% | +10.60% | +295.65% | +333.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.39B 5.41B 4.98B 4.71B 8.73B 591B 8.89B 58.31B 22.86B 287B 23.96B 23.46B 1,010B | 7.35B 6.22B 5.73B 5.42B 10.05B 680B 10.22B 67.08B 26.3B 330B 27.56B 26.99B 1,162B |
| Net income | 646M 547M 503M 476M 883M 59.77B 899M 5.9B 2.31B 28.97B 2.42B 2.37B 102B | 1.05B 890M 819M 775M 1.44B 97.22B 1.46B 9.59B 3.76B 47.13B 3.94B 3.86B 166B |
| Net Debt | -3.44B -2.92B -2.68B -2.54B -4.71B -319B -4.79B -31.44B -12.33B -155B -12.92B -12.65B -545B | -4.17B -3.53B -3.25B -3.07B -5.7B -386B -5.8B -38.04B -14.92B -187B -15.63B -15.31B -659B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/04/26 | 323.87 $ | +0.99% | 207,225 |
| 16/04/26 | 320.70 $ | +0.24% | 206,871 |
| 15/04/26 | 319.94 $ | +3.21% | 196,136 |
| 14/04/26 | 310.00 $ | +1.43% | 317,040 |
| 13/04/26 | 305.64 $ | -1.30% | 304,179 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ONC Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition